Show
Sort by
-
The use of [I-123]-2-iodo-L-phenylalanine as an early radiotherapy evaluation tool: In vitro R1M rabdomyosarcoma cell and in vivo mouse experiments
-
Use of [I-121]-2-iodo-L-phenylalanine as a tumor imaging agent in two dogs with synovial cell sarcoma
-
I-123/125-labelled 2-iodo-L-phenylalanine and 2-iodo-D-phenylalanine: comparative uptake in various tumour types and biodistribution in mice
-
Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.
-
Valine-based biphenylsulphonamide matrix metalloproteinase inhibitors as tumor imaging agents
-
Comparative biodistribution study of the new tumor tracer [I-123]-2-iodo-L-phenylalanine with [I-123]-2-iodo-L-tyrosine
-
Influence of sedation and data acquisition method on tracer uptake in animal models: [I-123]-2-iodo-L-phenylalanine in pentobarbital-sedated tumor-bearing athymic mice
-
In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy
-
Nuclear medicine in oncology
-
Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents
-
In vivo evaluation and dosimetry of I-123-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT in an R1M rhabdomyrosarcoma athymic mouse model
-
In vitro and in vivo evaluation of [I-123]-VEGF(165) as a potential tumor marker
-
Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice
-
In vivo evaluation of [I-123]-3-(4-iodobenzyl)-1,2,3,4-tetrahydro-8-hydroxychromeno [3,4-c]pyridin-5-one: a presumed dopamine D-4 receptor ligand for SPECT studies
-
Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of Tc-99m labelled epidermal growth factor
-
123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction
-
Biodistribution og 123/125I-VEGF in wild type NMRI and A2058 tumor inoculated athymic mice
-
Synthesis and in vivo evaluation in mice and rabbits of [123I]-3-(4-iodobenzyl)-8-methoxy-1,2,3,4-tetrahydrochromeno[3,4-c]pyridin-5-one as possible agent for imaging of the dopamine D4-receptor